Authors
Yongsi Zhao, Mengni Chang, Chengxin Hu, Xiao Chen, Changmin Wang, Wanzhe Zhang, Ye Li, Jun Ju, Shihong Chen, Linghua Kong, Shuyan Yu
Published in
Journal of advanced research. Oct 29, 2026. Epub Oct 29, 2026.
Abstract
Major depressive disorder (MDD) is a neuropsychiatric disorder associated with abnormal neuronal activity in specific brain regions. Recent evidence suggests that oxidative stress- and neuroinflammation-driven impairments in synaptic structure and neuronal function may contribute to depression, yet the precise mechanisms remain unclear. Lycopene (LYC) is a lipophilic dietary carotenoid that exhibits strong neuroprotective and antioxidant properties.
Here, we report that LYC alleviates chronic stress-induced neuroinflammation, oxidative stress, and impaired synaptic transmission by activating the PPAR-γ/SGK1/p-GSK3β/Nrf2/HO-1 signaling pathway.
Integrated transcriptomic and network pharmacology analyses prioritized PPAR-γ as a potential target of LYC. Moreover, pharmacological activation of PPAR-γ induced LYC-like effects by alleviating chronic stress-induced behavioral deficiency, oxidative stress and neuroinflammation, whereas CA1-local inhibition of PPAR-γ weakened LYC-mediated neuroprotection effects. Electrophysiological data further suggest that chronic stress weakened synaptic transmission and excitability in CA1 pyramidal neurons, while LYC improved the neuronal dysfunction through a PPAR-γ/SGK1/p-GSK3β/Nrf2/HO-1 signaling.
These findings demonstrate that LYC activates the PPAR-γ/SGK1/p-GSK3β/Nrf2/HO-1 signaling pathway to alleviate chronic stress-induced oxidative stress and neuroinflammation, thereby improving neuroplasticity and protecting against stress-related depression.
PMID:
42957161
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 10
- Comments 0